Jason G. Harb

miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts

Anna M. Eiring, Jason G. Harb, Paolo Neviani et al. · Cell · 2010 · 567 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Src homology 2 domain–containing inositol-5-phosphatase and CCAAT enhancer-binding protein β are targeted by miR-155 in B cells of Eμ-MiR-155 transgenic mice

Stefan Costinean, Sukhinder K. Sandhu, Irene M. Pedersen et al. · Blood · 2009 · 287 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells

Paolo Neviani, Jason G. Harb, Joshua J. Oaks et al. · Journal of Clinical Investigation · 2013 · 219 citations · Full text

Medicine, Oncology, Pharmacology +16

Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias

Christopher J. Walker, Joshua J. Oaks, Ramasamy Santhanam et al. · Blood · 2013 · 146 citations · Full text

Medicine, Oncology, Pharmacology +10

Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies

Joshua J. Oaks, Ramasamy Santhanam, Christopher J. Walker et al. · Blood · 2013 · 109 citations · Full text

Medicine, Hematology, Pharmacology +15